Last reviewed · How we verify
Synergy for Citrobacter Meningitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Gentamicin · Merck & Co.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Synergy for Citrobacter Meningitis patent landscape — cliff calendar, originator estates, attackable patents
- Synergy for Citrobacter Meningitis treatment landscape brief
- Synergy for Citrobacter Meningitis treatment updates RSS
Frequently asked questions about Synergy for Citrobacter Meningitis
What drugs treat Synergy for Citrobacter Meningitis?
Tracked treatments include Ramycin, Garamycin, Gentamicin.
What is the treatment for Synergy for Citrobacter Meningitis?
Standard treatment for Synergy for Citrobacter Meningitis includes Ramycin, Garamycin, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Synergy for Citrobacter Meningitis patent cliff · Synergy for Citrobacter Meningitis CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing